James Lefkowitz is Director at CorMedix Inc. (CRMD). They have made 1 open-market trade across 1 company since 2011, most recently 2011-12-15.
CIK 0001405891
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $372 since 2011, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRMD | BUY | 2011-12-15 | 2011-12-16 | $0.31 | $372 | -32.3% | -4.0% | -4.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.